http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002042056-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-537
filingDate 2000-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b995cdfee47107d6488ca32e3ca85fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66da55e800322dca44a7307f9711185
publicationDate 2002-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2002042056-A1
titleOfInvention Recognition of tumor-specific gene products in cancer
abstract The invention relates to the field of cancer diagnosis and the application of diagnostic techniques in pathology and hematology. Specifically, the invention relates to flow cytometric techniques for the detection of chromosomal aberrations and the detection of tumor specific gene products exclusively expressed by tumor cells containing said chromosomal aberrations. The invention provides a method to detect chromosomal aberrations in a biological sample via the exclusive detection of tumor-specific gene-product using at least two different probes directed against the gene-product.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007061684-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7993850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180366-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009226933-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9034658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011020822-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101479543-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009305305-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2428798-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013209988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006172345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006160106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10018632-B2
priorityDate 1997-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66602817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226498829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265

Total number of triples: 43.